Bell CE, Eisenberg D (xaneiro de 1996). "Crystal structure of diphtheria toxin bound to nicotinamide adenine dinucleotide". Biochemistry35 (4): 1137–49. PMID8573568. doi:10.1021/bi9520848.
Choe S, Bennett MJ, Fujii G, Curmi PM, Kantardjieff KA, Collier RJ, Eisenberg D (May 1992). "The crystal structure of diphtheria toxin". Nature357 (6375): 216–22. Bibcode:1992Natur.357..216C. PMID1589020. doi:10.1038/357216a0.
Bell CE, Eisenberg D (xaneiro de 1997). "Crystal structure of nucleotide-free diphtheria toxin". Biochemistry36 (3): 481–8. PMID9012663. doi:10.1021/bi962214s.
Bell CE, Eisenberg D (xaneiro de 1996). "Crystal structure of diphtheria toxin bound to nicotinamide adenine dinucleotide". Biochemistry35 (4): 1137–49. PMID8573568. doi:10.1021/bi9520848.
Woo JH, Lee YJ, Neville DM, Frankel AE (2010). "Pharmacology of anti-CD3 diphtheria immunotoxin in CD3 positive T-cell lymphoma trials". Immunotherapy of Cancer. Methods in Molecular Biology 651. pp. 157–75. ISBN978-1-60761-785-3. PMID20686966. doi:10.1007/978-1-60761-786-0_10.
Auger A, Park M, Nitschke F, Minassian LM, Beilhartz GL, Minassian BA, Melnyk RA (agosto de 2015). "Efficient Delivery of Structurally Diverse Protein Cargo into Mammalian Cells by a Bacterial Toxin". Molecular Pharmaceutics12 (8): 2962–71. PMID26103531. doi:10.1021/acs.molpharmaceut.5b00233.
Beilhartz GL, Sugiman-Marangos SN, Melnyk RA (outubro de 2017). "Repurposing bacterial toxins for intracellular delivery of therapeutic proteins". Biochemical Pharmacology142: 13–20. PMID28408344. doi:10.1016/j.bcp.2017.04.009.
Bell CE, Eisenberg D (xaneiro de 1996). "Crystal structure of diphtheria toxin bound to nicotinamide adenine dinucleotide". Biochemistry35 (4): 1137–49. PMID8573568. doi:10.1021/bi9520848.
Choe S, Bennett MJ, Fujii G, Curmi PM, Kantardjieff KA, Collier RJ, Eisenberg D (May 1992). "The crystal structure of diphtheria toxin". Nature357 (6375): 216–22. Bibcode:1992Natur.357..216C. PMID1589020. doi:10.1038/357216a0.
Bell CE, Eisenberg D (xaneiro de 1997). "Crystal structure of nucleotide-free diphtheria toxin". Biochemistry36 (3): 481–8. PMID9012663. doi:10.1021/bi962214s.
Bell CE, Eisenberg D (xaneiro de 1996). "Crystal structure of diphtheria toxin bound to nicotinamide adenine dinucleotide". Biochemistry35 (4): 1137–49. PMID8573568. doi:10.1021/bi9520848.
Woo JH, Lee YJ, Neville DM, Frankel AE (2010). "Pharmacology of anti-CD3 diphtheria immunotoxin in CD3 positive T-cell lymphoma trials". Immunotherapy of Cancer. Methods in Molecular Biology 651. pp. 157–75. ISBN978-1-60761-785-3. PMID20686966. doi:10.1007/978-1-60761-786-0_10.
Auger A, Park M, Nitschke F, Minassian LM, Beilhartz GL, Minassian BA, Melnyk RA (agosto de 2015). "Efficient Delivery of Structurally Diverse Protein Cargo into Mammalian Cells by a Bacterial Toxin". Molecular Pharmaceutics12 (8): 2962–71. PMID26103531. doi:10.1021/acs.molpharmaceut.5b00233.
Beilhartz GL, Sugiman-Marangos SN, Melnyk RA (outubro de 2017). "Repurposing bacterial toxins for intracellular delivery of therapeutic proteins". Biochemical Pharmacology142: 13–20. PMID28408344. doi:10.1016/j.bcp.2017.04.009.